Daniel Lüftenegger is currently the Head of Medical Affairs Central Cluster at neuraxpharm, specializing in multiple sclerosis, Alzheimer’s disease, neurology, and virology with a focus on HIV and hepatitis. They previously held positions as a Senior Medical Advisor at ViiV Healthcare and a Senior Medical Manager for the MS portfolio at Biogen. Daniel has extensive experience in medical sciences and research, having worked with various companies including MSD Sharp & Dohme and Gilead Sciences, and holds a doctorate in virology from TU Dresden. They earned a Diplom in biology from Universität Würzburg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices